Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction
Audrey H. Wu,Keith D. Aaronson,Steven F. Bolling,Francis D. Pagani,Kathy Welch,Todd M. Koelling +5 more
Reads0
Chats0
TLDR
There is no clearly demonstrable mortality benefit conferred by MVA for significant MR with severe LV dysfunction, and a prospective randomized control trial is warranted for further study of mortality with MVA in this population.About:
This article is published in Journal of the American College of Cardiology.The article was published on 2005-02-01 and is currently open access. It has received 637 citations till now. The article focuses on the topics: Mitral valve annuloplasty & Mitral regurgitation.read more
Citations
More filters
Journal ArticleDOI
Effect of Mitral Valve Surgery in Patients With Dilated Cardiomyopathy and Severe Functional Mitral Regurgitation.
Hyemoon Chung,Makoto Amaki,Seiji Takashio,Hiroyuki Takahama,Takahiro Ohara,Takuya Hasegawa,Yasuo Sugano,Tomoyuki Fujita,Junjiro Kobayashi,Masanori Asakura,Hideaki Kanzaki,Toshihisa Anzai,Masafumi Kitakaze +12 more
TL;DR: Surgery for severe FMR provides better long-term outcomes in patients with DCM, and multivariate Cox regression analysis using clinical data revealed that MV surgery and diabetes mellitus were independent predictors of clinical outcomes after adjusting for age and sex.
Journal ArticleDOI
Left Ventricular Stroke Work Index Associated With Outcome After Mitral Valve Surgery for Functional Regurgitation in Nonischemic Dilated Cardiomyopathy
Noriyuki Kashiyama,Koichi Toda,Shigeru Miyagawa,Yasushi Yoshikawa,Hiroki Hata,Daisuke Yoshioka,Yoshiki Sawa +6 more
TL;DR: T thorough hemodynamic investigations prior to surgery could provide useful indications regarding mitral valve surgery in patients with advanced non-ischemic dilated cardiomyopathy and functional mitral regurgitation, contributing to an improvement in their clinical outcomes.
Journal ArticleDOI
Restrictive mitral annuloplasty with or without coronary artery bypass grafting in ischemic mitral regurgitation.
Satoshi Kainuma,Koichi Toda,Shigeru Miyagawa,Yasushi Yoshikawa,Hiroki Hata,Daisuke Yoshioka,Takuji Kawamura,Ai Kawamura,Takayoshi Ueno,Toru Kuratani,Haruhiko Kondoh,Takafumi Masai,Arudo Hiraoka,Taichi Sakaguchi,Hidenori Yoshitaka,Yukitoshi Shirakawa,Toshiki Takahashi,Shunsuke Saito,Osamu Monta,Junya Sado,Tetsuhisa Kitamura,Sho Komukai,Atsushi Hirayama,Kazuhiro Taniguchi,Yoshiki Sawa +24 more
TL;DR: In patients with ischaemic mitral regurgitation, the impact of mitral valve surgery with concomitant coronary artery bypass grafting with and without CABG on post‐operative survival and left ventricular reverse remodelling remains unknown.
Journal ArticleDOI
Long-Term Results of Left Ventricular Reconstructive Surgery in Patients With Ischemic Dilated Cardiomyopathy : A Multicenter Study
Koji Takeda,Goro Matsumiya,Taichi Sakaguchi,Hajime Matsue,Takafumi Masai,Shigeaki Otake,Kazuhiro Taniguchi,Yoshiki Sawa +7 more
TL;DR: LVR can be performed with a low operative mortality and provide satisfactory long-term survival by restoring the dilated left ventricle and improving systolic function, and these improvements were still significant in the late period.
Journal ArticleDOI
Reasons for Screen Failure for Transcatheter Mitral Valve Repair and Replacement
Brian J. Forrestal,Jaffar M. Khan,Jaffar M. Khan,Rebecca Torguson,Brian C. Case,Lowell Safren,Nayeem Nasher,Gemma Reddin,Lowell F. Satler,Itsik Ben-Dor,Christian Shults,Erin C. Collins,Toby Rogers,Toby Rogers,Ron Waksman +14 more
TL;DR: In this paper, the authors analyzed the rates that patients with mitral regurgitation were excluded from transcatheter mitral valve therapies and reasons why, and found that the primary reason for exclusion was clinical in 38.5%, issues related to patient preference of care delivery in 38, anatomical in 13.7%, and futility in 9.0%.
References
More filters
Journal ArticleDOI
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Bertram Pitt,Faiez Zannad,Willem J. Remme,Robert J. Cody,Alain Castaigne,Alfonso Perez,Jolie Palensky,Janet Wittes +7 more
TL;DR: Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
Journal ArticleDOI
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Arthur J. Moss,Wojciech Zareba,W. Jackson Hall,Helmut U. Klein,David J. Wilber,David S. Cannom,James P. Daubert,Steven L. Higgins,Mary W. Brown,Mark L. Andrews +9 more
TL;DR: In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.
Journal ArticleDOI
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
Michael R. Bristow,Leslie A. Saxon,John P. Boehmer,Steven K. Krueger,David A. Kass,Teresa De Marco,Peter E. Carson,Lorenzo DiCarlo,David L. DeMets,Bill G. White,Dale W DeVries,Arthur M. Feldman +11 more
TL;DR: In this paper, the authors tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays.
Journal ArticleDOI
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt,Faiez Zannad,Willem J. Remme,Robert J. Cody,Alain Castaigne,Alfonso Perez,Jolie Palensky,Janet Wittes +7 more